General Fusion (General Fusion Group Ltd. — pending Nasdaq: GFUZ)

A differentiated, lower-physics-risk fusion path (no superconducting magnets, no megajoule lasers) that just printed a real, peer-review-bound plasma-heating milestone on a commercially-scaled demo machine — and is refilling the balance sheet via a ~$1B Nasdaq SPAC plus a named commercial offtake counterparty in Italy.

• Distinctive MTF approach removes two of fusion's hardest/most expensive subsystems: it heats plasma purely by mechanical compression with a lithium liner — no HTS magnets (CFS/Tokamak Energy's cost driver) and no high-power laser array (Xcimer/Marvel). Lower bill-of-materials if the physics scales.
• Tangible, dated progress: LM26 built in under two years and on Jun 22 2026 reached ~0.72 keV electron temperature (a >3x compression-driven gain), with the next rung (1 keV) explicitly in sight — milestones are being hit, not just promised.
• Balance sheet de-risked vs. the May-2025 near-death: US$22M + ~US$51M SAFE bridged the gap, and the SPAC adds up to ~US$230M trust + US$107.7M committed/oversubscribed PIPE — a multi-year runway if redemptions are contained.
• First commercial pull-through signal: the Jun 24 2026 Renexia (Toto Group) framework for site evaluation → offtake → permitting in Italy, plus Renexia already sitting on GF's Market Development Advisory Committee — a real counterparty, not a press-release MOU with a stranger.
• Blue-chip cap table and lab credibility: Jeff Bezos, Temasek, BDC Capital, Chrysalix; collaborations with UKAEA, Princeton Plasma Physics Lab, and General Atomics lend technical legitimacy.
• Going public makes it one of very few ways for public investors to own a fusion pure-play (alongside TAE via Trump Media/DJT) at a ~$1B entry vs. CFS (~$3B private), Helion ($1.5B raised), TAE ($6B merger).

A pre-revenue science project that nearly ran out of cash 13 months ago, is still many physics milestones and a decade-plus from any commercial net-energy, and is reaching the public market via a redemption-prone SPAC at a ~$1B valuation with no earnings to underwrite it — classic late-cycle, financing-gated, binary deep-tech.

• Net energy is not close: 0.72 keV is ~14x below the 10 keV rung and far below the full Lawson criterion (density × temperature × confinement) needed for net energy in the plasma — and the plasma result is still 'submitted for peer review,' not yet independently validated.
• Commercial power plant is a mid-2030s target — a decade-plus horizon with enormous engineering risk beyond plasma physics (tritium breeding, lithium-6 supply, neutron-tolerant materials — the DOE itself flagged a 'materials wall' in Jun 2026). A perfect demo doesn't equal a grid plant.
• Acute, recurring financing risk: the May-2025 layoffs (~25% of ~140 staff) and US$125M gap show how fast capital can vanish; the 'pay-to-play' US$22M round and SAFE structure signal distressed terms. The SPAC's ~US$230M trust assumes no redemptions — historically a heroic assumption for science-story SPACs.
• SPAC quality concerns: listing via Spring Valley Acquisition Corp. III rather than a traditional IPO, at ~$1B with zero revenue, invites de-SPAC drawdown risk; many 2021-vintage energy/EV SPACs lost the majority of value post-close.
• Out-raised and out-resourced by rivals: CFS (~$3B, magnet-tokamak, Google 200MW offtake), Helion ($1.5B, Microsoft 2028 deal), TAE ($1.79B), Pacific Fusion ($1B+ Series A). GF's ~$612M lifetime is mid-pack and it competes for the same scarce talent, capital, and offtake customers.
• Non-US issuer (British Columbia; SVAC redomiciling to BC, renamed General Fusion Group Ltd.) — analysis-only per QAI policy, not a buy/own recommendation. The Renexia deal is a non-binding framework (an 'agreement to work toward agreements').